News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
Tuesday, September 16, 2025Parexel a global clinical research organisation CRO has formed a strategic partnership with Paradigm Health to transform how clinical trials are designed and executed The collaboration aims to accelerate
Corstasis Therapeutics Gains FDA Approval for ENBUMYST™ (Bumetanide Nasal Spray) to Treat Edema Linked to Heart, Liver and Kidney Disease
Tuesday, September 16, 2025Corstasis Therapeutics has received approval from the US Food and Drug Administration FDA for ENBUMYST bumetanide nasal spray The treatment is indicated for oedema linked to congestive heart failure CHF
Amneal Receives U.S. FDA Approval for Sodium Oxybate Oral Solution
Friday, September 12, 2025Amneal Pharmaceuticals Inc has received approval from the US Food and Drug Administration FDA for its sodium oxybate oral solution mgmL through an Abbreviated New Drug Application
Sanofi’s SAR402663 Granted Fast Track Designation in the United States for Neovascular Age-Related Macular Degeneration
Thursday, September 11, 2025The US Food and Drug Administration FDA has granted fasttrack designation to Sanofis SAR a singledose intravitreal gene therapy being developed for the treatment of neovascular agerelated macular
U.S. FDA approves INLEXZO™ (gemcitabine intravesical system), set to transform treatment for certain bladder cancers
Wednesday, September 10, 2025Johnson Johnsontoday announced that the US Food and Drug Administration FDA has approved INLEXZO gemcitabine intravesical system a new approach for treating patients with specific types of bladder cancer
New Digital Health Platform Launched in Germany to Enhance R&D Collaborations
Wednesday, September 10, 2025A new digital health platform targeting RD collaborations has been launched in Germany to streamline pharmaceutical innovations
European Commission Approves New Biopharmaceutical for Rare Disease
Wednesday, September 10, 2025The European Commission has granted marketing authorization for a new biopharmaceutical aimed at treating a rare disease marking a significant advancement in the area
New Clinical Trials Achieve Milestones in Biologic Treatments in Europe
Tuesday, September 09, 2025Significant progress has been made in European clinical trials focusing on biologic treatments
European Pharma Companies Collaborate on New Sustainable Drug Manufacturing Initiative
Tuesday, September 09, 2025European pharmaceutical companies are joining forces for a groundbreaking initiative in sustainable drug manufacturing
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
Tuesday, September 09, 2025Cocrystal Pharma Inc Nasdaq COCP has announced that the US Food and Drug Administration FDA has granted clearance to proceed with a Phase b challenge study evaluating CDI the Companys
